Topiramate for the Treatment of Methamphetamine Dependence - 1

• Status: Completed
• Trial end date: 2008-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the efficacy and safety of topiramate as compared to placebo in reducing methamphetamine use in subjects with methamphetamine dependence.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Institute on Drug Abuse (NIDA)
• Treatments: Methamphetamine; Topiramate

Criteria

Inclusion Criteria:

• Treatment seeking individuals as the time of the study

• Must be able to proved written informed consent

• Must have a body mass index greater than 18 kg/m(2)

• Must meet DSM-IV criteria for methamphetamine dependence

• Must currently be using methamphetamine as confirmed by a positive urine test over the past 14 days

• If female of child bearing potential, must agree to use birth control

Exclusion Criteria:

• Please contact the site for more information